Drais Pharmaceuticals

About:

Drais Pharmaceuticals is a drug development company involved in the development of novel compounds in a variety of therapeutic areas.

Website: http://draispharma.com

Top Investors: Sutter Hill Ventures, InterWest Partners

Description:

Drais Pharmaceuticals, Inc. is a venture capital supported drug development company with an exciting new business model. Through strong relationships with Astellas Pharma Inc. and our venture capital investors - InterWest Partners, Sutter Hill Ventures, and Astellas Venture Management LLC, we have created multiple virtual companies to enable the development of interesting novel compounds in a variety of therapeutic areas. Our focus is on early stage development through proof of concept. Our business model relies on a small internal team who provide drug development services to those virtual companies via vendors and CROs. Our internal experts are able to move compounds rapidly through key development milestones and decision points, thus de-risking programs early in development.

Total Funding Amount:

$33M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bridgewater, New Jersey, United States

Founded Date:

2007-01-01

Contact Email:

HR(AT)draispharma.com

Founders:

Donna L. Tempel

Number of Employees:

11-50

Last Funding Date:

2012-06-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai